An information aid for newly diagnosed multiple sclerosis patients improves disease knowledge and satisfaction with care

Author:

Solari A.1,Martinelli V2,Trojano M3,Lugaresi A4,Granella F5,Giordano A6,Messmer Uccelli M7,D'Alessandro R8,Pucci E9,Confalonieri P10,Borreani C11,

Affiliation:

1. Unit of Neuroepidemiology, Foundation IRCCS Neurological Institute C. Besta, Milan, Italy,

2. Department of Neurology, Scientific Institute Hospital San Raffaele, Milan, Italy

3. Departments of Neurological and Psychiatric Sciences, University of Bari, Bari, Italy

4. Department of Neuroscience and Imaging, University G. D'Annunzio, Chieti, Italy

5. Department of Neurosciences, Neurology Unit, University of Parma, Parma, Italy

6. Unit of Neuroepidemiology, Foundation IRCCS Neurological Institute C. Besta, Milan, Italy

7. Department of Health Services and Research, Italian MS Society, Genoa, Italy

8. Department of Clinical Neurology, University of Bologna, Bologna, Italy

9. Neurology Department, Macerata Hospital, Macerata, Italy

10. Department of Neuromuscular Diseases, Foundation IRCCS Neurological Institute C. Besta, Milan, Italy

11. Psychology Unit, National Cancer Institute Foundation, Milan, Italy

Abstract

Background: Patients report information deficits in the period surrounding diagnosis of multiple sclerosis (MS). We assessed the effectiveness of an add-on information aid for newly diagnosed MS patients. Methods: We randomly assigned 120 newly diagnosed MS patients from five Italian centres to diagnosis disclosure (current practice at the centre) or current practice plus information aid (ISRCTN81072971). The information aid consisted of a personal interview with a physician using a navigable compact disc and a take-home booklet. The primary composite endpoint was score in the highest tertile of MS knowledge and satisfaction with care questionnaires. Other endpoints were safety; treatment adherence; extra contacts/consultations; switching of care centre; and changes in Hospital Anxiety and Depression Scale and Control Preference Scale scores. Results: At 1 month, 30/60 intervention and 8/60 control patients achieved the primary endpoint (odds ratio [OR] 6.5, 95% CI 2.6—16.0; p < 0.001; number needed to treat [NNT] 3). Figures at 6 months were 26/60 intervention and 11/60 control patients (OR 3.4, 95% CI 1.5—7.8; p = 0.04; NNT 4). There were no adverse events. No significant treatment effects were seen on secondary outcomes. Conclusion: The information aid was safe and significantly associated with attainment of the primary outcome at 1 and 6 months.

Publisher

SAGE Publications

Subject

Neurology (clinical),Neurology

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3